Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 23, 2016
ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times...
-
Mar 15, 2016World's largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the national availability of Dario in the U.S. The U.S. rollout follows the...
-
Mar 9, 2016Broadens platform technology's applications beyond mHealth and into health and non-health related industrial markets
LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today the U.S. Patent and Trademark Office has issued the Company patent #9257038...
-
Mar 4, 2016Company Effects a 1-for-18 Reverse Stock Split
LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective...
-
Feb 9, 2016- FDA clearance announced on December 22nd
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, reported financial and operational results for the year ended December 31, 2015 and provided an...
-
Jan 26, 2016- Sales channels to include direct-to-consumer, e-commerce, third-party distributors
CAESAREA, Israel / LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the...
-
Dec 22, 2015Smartphone-based blood glucose monitor with unique all-in-one design cleared for launch in the world's largest diabetes market
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that the United States Food and Drug Administration (FDA) has granted 510(k)...
-
Dec 16, 2015
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced its personalized smart blood glucose meter has recently been featured in numerous...
-
Nov 19, 2015A LabStyle distributor participated in the investment
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it has closed on an offering raising approximately $2.3 million in proceeds...
-
Nov 16, 2015Mobile healthcare apps and social media become platform for user-centric revolution enabling people to take charge of their health
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that Facebook (NASDAQ:FB) published a case study about the Company's social media...